[HTML] nature.com

[HTML][HTML] 2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer

M Vogsen, M Naghavi-Behzad, FG Harbo… - Scientific Reports, 2023 - nature.com
This study aimed to compare CE-CT and 2-[18F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …
被引用次数：8 相关文章

2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer

M Vogsen, M Naghavi-Behzad, FG Harbo… - Scientific …, 2023 - ui.adsabs.harvard.edu
This study aimed to compare CE-CT and 2-[18 F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …

2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer.

M Vogsen, M Naghavi-Behzad, FG Harbo… - Scientific …, 2023 - europepmc.org
This study aimed to compare CE-CT and 2-[18 F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …

2-[18F] FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer

M Vogsen, M Naghavi-Behzad, FG Harbo… - Scientific …, 2023 - pubmed.ncbi.nlm.nih.gov
This study aimed to compare CE-CT and 2-[18 F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …
[HTML] nih.gov

[HTML][HTML] 2-[18F] FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer

M Vogsen, M Naghavi-Behzad, FG Harbo… - Scientific …, 2023 - ncbi.nlm.nih.gov
This study aimed to compare CE-CT and 2-[18 F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …

2-[18F] FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer

M Vogsen, M Naghavi-Behzad… - Scientific …, 2023 - portal.findresearcher.sdu.dk
This study aimed to compare CE-CT and 2-[18 F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …
[PDF] sabinai-neji.com

[PDF][PDF] 2‑[18F] FDG‑PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer

M Vogsen, M Naghavi‑Behzad, FG Harbo… - Scientific …, 2023 - sabinai-neji.com
Methods Study design and patients. In this prospective observational study, the response to
first-line treatment for MBC was compared for CE-CT and 2-[18F] FDG-PET/CT, with patients …

2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer.

M Vogsen, M Naghavi-Behzad, FG Harbo… - Scientific …, 2023 - search.ebscohost.com
This study aimed to compare CE-CT and 2-[< sup> 18 F] FDG-PET/CT for response
monitoring metastatic breast cancer (MBC). The primary objective was to predict progression …

2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer.

M Vogsen, M Naghavi-Behzad, FG Harbo… - Scientific …, 2023 - europepmc.org
This study aimed to compare CE-CT and 2-[18 F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …